Full Text View
Tabular View
No Study Results Posted
Related Studies
High Dose Cyclophosphamide for Treatment of Scleroderma
This study is ongoing, but not recruiting participants.
Study NCT00501995   Information provided by Johns Hopkins University
First Received: July 13, 2007   Last Updated: July 25, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Scleroderma
Additional conditions recognized in this trial
Scleroderma, Diffuse
Scleroderma, Localized
Scleroderma, Systemic
More general conditions related to this trial
Connective Tissue Diseases
Skin Diseases
Interventions listed in this trial
High Dose Cyclophosphamide
Additional drug interventions recognized in this trial
Cyclophosphamide
More general drug interventions related to this trial
Alkylating Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antirheumatic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Johns Hopkins University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services